A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION). Conference

Kotecha, Rupesh, Odia, Yazmin, Chen, Zhijian et al. (2024). A phase I/II study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metastases (ADORATION). . JOURNAL OF CLINICAL ONCOLOGY, 42(16),

cited authors

  • Kotecha, Rupesh; Odia, Yazmin; Chen, Zhijian; Starosciak, Amy K; Rubens, Muni; La Rosa, Alonso; Herrera, Susana; Menendez, Miguel A Ramirez; Pow-Sang, Cristina I; Ramos, Suyen; Perez, Jennifer; Ahluwalia, Manmeet Singh; Mehta, Minesh P

authors

date/time interval

  • May 29, 2024 -

publication date

  • June 1, 2024

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • ELECTR NETWORK

Conference

  • Special Clinical Science Symposia

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

volume

  • 42

issue

  • 16